BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24870244)

  • 1. Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression.
    Lee Y; Dominy JE; Choi YJ; Jurczak M; Tolliday N; Camporez JP; Chim H; Lim JH; Ruan HB; Yang X; Vazquez F; Sicinski P; Shulman GI; Puigserver P
    Nature; 2014 Jun; 510(7506):547-51. PubMed ID: 24870244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 represses gluconeogenesis via inhibition of the transcriptional coactivator PGC1α.
    Bhalla K; Liu WJ; Thompson K; Anders L; Devarakonda S; Dewi R; Buckley S; Hwang BJ; Polster B; Dorsey SG; Sun Y; Sicinski P; Girnun GD
    Diabetes; 2014 Oct; 63(10):3266-78. PubMed ID: 24947365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis.
    Sakai M; Matsumoto M; Tujimura T; Yongheng C; Noguchi T; Inagaki K; Inoue H; Hosooka T; Takazawa K; Kido Y; Yasuda K; Hiramatsu R; Matsuki Y; Kasuga M
    Nat Med; 2012 Mar; 18(4):612-7. PubMed ID: 22426420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis.
    Dominy JE; Lee Y; Jedrychowski MP; Chim H; Jurczak MJ; Camporez JP; Ruan HB; Feldman J; Pierce K; Mostoslavsky R; Denu JM; Clish CB; Yang X; Shulman GI; Gygi SP; Puigserver P
    Mol Cell; 2012 Dec; 48(6):900-13. PubMed ID: 23142079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Methionine Transamination Pathway Controls Hepatic Glucose Metabolism through Regulation of the GCN5 Acetyltransferase and the PGC-1α Transcriptional Coactivator.
    Tavares CD; Sharabi K; Dominy JE; Lee Y; Isasa M; Orozco JM; Jedrychowski MP; Kamenecka TM; Griffin PR; Gygi SP; Puigserver P
    J Biol Chem; 2016 May; 291(20):10635-45. PubMed ID: 27022023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha.
    Lerin C; Rodgers JT; Kalume DE; Kim SH; Pandey A; Puigserver P
    Cell Metab; 2006 Jun; 3(6):429-38. PubMed ID: 16753578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1.
    Güller M; Toualbi-Abed K; Legrand A; Michel L; Mauviel A; Bernuau D; Daniel F
    World J Gastroenterol; 2008 Nov; 14(41):6339-46. PubMed ID: 19009649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.
    Rodgers JT; Lerin C; Haas W; Gygi SP; Spiegelman BM; Puigserver P
    Nature; 2005 Mar; 434(7029):113-8. PubMed ID: 15744310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
    Takahashi-Yanaga F; Sasaguri T
    Cell Signal; 2008 Apr; 20(4):581-9. PubMed ID: 18023328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α.
    Hanse EA; Mashek DG; Becker JR; Solmonson AD; Mullany LK; Mashek MT; Towle HC; Chau AT; Albrecht JH
    Cell Cycle; 2012 Jul; 11(14):2681-90. PubMed ID: 22751438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
    Ong CS; Zhou J; Ong CN; Shen HM
    Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
    Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
    J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
    Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation.
    Kelly TJ; Lerin C; Haas W; Gygi SP; Puigserver P
    J Biol Chem; 2009 Jul; 284(30):19945-52. PubMed ID: 19491097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation.
    Chen B; Pan H; Zhu L; Deng Y; Pollard JW
    Mol Endocrinol; 2005 Aug; 19(8):1978-90. PubMed ID: 15845746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
    Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
    Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCAF improves glucose homeostasis by suppressing the gluconeogenic activity of PGC-1α.
    Sun C; Wang M; Liu X; Luo L; Li K; Zhang S; Wang Y; Yang Y; Ding F; Gu X
    Cell Rep; 2014 Dec; 9(6):2250-62. PubMed ID: 25497092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGC-1beta in the regulation of hepatic glucose and energy metabolism.
    Lin J; Tarr PT; Yang R; Rhee J; Puigserver P; Newgard CB; Spiegelman BM
    J Biol Chem; 2003 Aug; 278(33):30843-8. PubMed ID: 12807885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
    Erion DM; Yonemitsu S; Nie Y; Nagai Y; Gillum MP; Hsiao JJ; Iwasaki T; Stark R; Weismann D; Yu XX; Murray SF; Bhanot S; Monia BP; Horvath TL; Gao Q; Samuel VT; Shulman GI
    Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11288-93. PubMed ID: 19549853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.